Analysts Set Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Price Target at $19.25

Sabra Health Care REIT, Inc. (NASDAQ:SBRA) has earned an average recommendation of “Moderate Buy” from the nine brokerages that are currently covering the company, Marketbeat reports. Two research analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company. The average 12-month price target among brokers that have covered the stock in the last year is $19.25.

A number of research firms have recently commented on SBRA. Citizens Jmp upgraded Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, January 7th. Mizuho reiterated a “neutral” rating and issued a $20.00 price objective on shares of Sabra Health Care REIT in a research note on Thursday, December 5th. Wells Fargo & Company upgraded Sabra Health Care REIT from an “equal weight” rating to an “overweight” rating and lifted their price objective for the stock from $16.00 to $20.00 in a research note on Tuesday, October 1st. JMP Securities upgraded Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 price objective on the stock in a research note on Tuesday, January 7th. Finally, Scotiabank lifted their price objective on Sabra Health Care REIT from $17.00 to $18.00 and gave the stock a “sector perform” rating in a research note on Friday, October 11th.

Sabra Health Care REIT Price Performance

NASDAQ SBRA opened at $16.80 on Wednesday. Sabra Health Care REIT has a fifty-two week low of $12.83 and a fifty-two week high of $20.03. The stock’s 50-day moving average is $17.88 and its two-hundred day moving average is $17.49. The company has a debt-to-equity ratio of 0.90, a current ratio of 4.16 and a quick ratio of 4.16. The firm has a market cap of $3.97 billion, a P/E ratio of 40.98, a price-to-earnings-growth ratio of 2.20 and a beta of 1.26.

Sabra Health Care REIT (NASDAQ:SBRA) last posted its quarterly earnings data on Thursday, October 31st. The real estate investment trust reported $0.13 EPS for the quarter, missing analysts’ consensus estimates of $0.35 by ($0.22). The business had revenue of $178.00 million during the quarter, compared to the consensus estimate of $177.19 million. Sabra Health Care REIT had a return on equity of 3.51% and a net margin of 14.20%. During the same quarter in the previous year, the firm posted $0.34 earnings per share. On average, analysts anticipate that Sabra Health Care REIT will post 1.39 earnings per share for the current fiscal year.

Sabra Health Care REIT Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, November 29th. Investors of record on Friday, November 15th were given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 7.14%. The ex-dividend date of this dividend was Friday, November 15th. Sabra Health Care REIT’s dividend payout ratio (DPR) is presently 292.68%.

Institutional Investors Weigh In On Sabra Health Care REIT

Institutional investors have recently added to or reduced their stakes in the stock. Geode Capital Management LLC boosted its holdings in Sabra Health Care REIT by 1.7% during the third quarter. Geode Capital Management LLC now owns 6,294,798 shares of the real estate investment trust’s stock valued at $117,165,000 after purchasing an additional 104,533 shares in the last quarter. JPMorgan Chase & Co. boosted its holdings in Sabra Health Care REIT by 222.4% during the third quarter. JPMorgan Chase & Co. now owns 9,886,917 shares of the real estate investment trust’s stock valued at $183,996,000 after purchasing an additional 6,819,919 shares in the last quarter. Barclays PLC boosted its holdings in Sabra Health Care REIT by 56.1% during the third quarter. Barclays PLC now owns 678,397 shares of the real estate investment trust’s stock valued at $12,624,000 after purchasing an additional 243,895 shares in the last quarter. Vestcor Inc boosted its holdings in Sabra Health Care REIT by 62.5% during the third quarter. Vestcor Inc now owns 207,918 shares of the real estate investment trust’s stock valued at $3,869,000 after purchasing an additional 79,956 shares in the last quarter. Finally, Franklin Resources Inc. boosted its holdings in Sabra Health Care REIT by 12.3% during the third quarter. Franklin Resources Inc. now owns 524,917 shares of the real estate investment trust’s stock valued at $9,543,000 after purchasing an additional 57,551 shares in the last quarter. 99.40% of the stock is owned by institutional investors and hedge funds.

About Sabra Health Care REIT

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.